Drilling Down Into Pfizer Inc. (PFE)

Pfizer Inc. (PFE) is an interesting player in the Healthcare space, with a focus on Drug Manufacturers – Major. The stock has been active on the tape, currently trading at $35.71, up from yesterday’s close by 0.08%. Given the stock’s recent action, it seemed like a good time to take a closer look at the company’s recent data.

Fundamental Analysis

Pfizer Inc. (PFE) currently trades with a market capitalization of $212.72 Billion. That value represents a market adjusting for revenues that have been growing by 0.99 % on a quarterly year/year basis as of the company’s last quarterly report.

You can get a sense of how sustainable that is by a levered free cash flow of $14.88 Billion over the past twelve months. Generally speaking, earnings are expected to hold steady in coming quarters. Analysts are forecasting earnings of $0.75 on a per share basis this quarter. Perhaps, that suggests something about why 0.24% of the outstanding share supply is held by institutional investors.

Technical Analysis

As most professionals know, technical analysis can offer critical insights into what smart money and insiders think about a stock’s prospects going forward. Looking at the stock’s movement on the chart, Pfizer Inc. recorded a 52-week high of $39.43. It is now trading 3.72% off that level. The stock is trading $35.92 its 50-day moving average by 0.21%. The stock carved out a 52-week low down at $31.67.

In recent action, Pfizer Inc. (PFE) has made a move of -2.24% over the past month, which has come on Strong relative transaction volume. Over the trailing year, the stock is underperforming the S&P 500 by 15.08, and it’s gotten there by action that has been less volatile on a day-to-day basis than most other stocks on the exchange. In terms of the mechanics underlying that movement, traders will want to note that the stock is trading on a float of 1.10% with $5.94 Billion sitting short, betting on future declines. That suggests something of the likelihood of a short squeeze in shares of PFE.

Previous articleSymantec Corp. (SYMC): From Top to Bottom
Next articleThe Case for and Against NVIDIA Corp. (NVDA)